168 related articles for article (PubMed ID: 21291355)
1. Optimization of lentiviral vectors generation for biomedical and clinical research purposes: contemporary trends in technology development and applications.
Kumar P; Woon-Khiong C
Curr Gene Ther; 2011 Apr; 11(2):144-53. PubMed ID: 21291355
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in lentiviral vector development and applications.
Mátrai J; Chuah MK; VandenDriessche T
Mol Ther; 2010 Mar; 18(3):477-90. PubMed ID: 20087315
[TBL] [Abstract][Full Text] [Related]
3. Generation of human β-thalassemia induced pluripotent stem cells from amniotic fluid cells using a single excisable lentiviral stem cell cassette.
Fan Y; Luo Y; Chen X; Li Q; Sun X
J Reprod Dev; 2012; 58(4):404-9. PubMed ID: 22498813
[TBL] [Abstract][Full Text] [Related]
4. Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted β-thalassemia patient.
Tubsuwan A; Abed S; Deichmann A; Kardel MD; Bartholomä C; Cheung A; Negre O; Kadri Z; Fucharoen S; von Kalle C; Payen E; Chrétien S; Schmidt M; Eaves CJ; Leboulch P; Maouche-Chrétien L
Stem Cells; 2013 Sep; 31(9):1785-94. PubMed ID: 23712774
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral vectors in clinical trials: Current status.
D'Costa J; Mansfield SG; Humeau LM
Curr Opin Mol Ther; 2009 Oct; 11(5):554-64. PubMed ID: 19806504
[TBL] [Abstract][Full Text] [Related]
6. Biosafety challenges for use of lentiviral vectors in gene therapy.
Rothe M; Modlich U; Schambach A
Curr Gene Ther; 2013 Dec; 13(6):453-68. PubMed ID: 24195603
[TBL] [Abstract][Full Text] [Related]
7. Concise review on optimized methods in production and transduction of lentiviral vectors in order to facilitate immunotherapy and gene therapy.
Gouvarchin Ghaleh HE; Bolandian M; Dorostkar R; Jafari A; Pour MF
Biomed Pharmacother; 2020 Aug; 128():110276. PubMed ID: 32502836
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in lentiviral vectors for gene therapy.
Wang X; Ma C; Rodríguez Labrada R; Qin Z; Xu T; He Z; Wei Y
Sci China Life Sci; 2021 Nov; 64(11):1842-1857. PubMed ID: 34708326
[TBL] [Abstract][Full Text] [Related]
9. Advances in lentiviral vectors: a patent review.
Picanco-Castro V; de Sousa Russo-Carbolante EM; Tadeu Covas D
Recent Pat DNA Gene Seq; 2012 Aug; 6(2):82-90. PubMed ID: 22670608
[TBL] [Abstract][Full Text] [Related]
10. [Improvements of lentiviral vector and its application in gene therapy of hematological diseases].
Zhu HH; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):208-12. PubMed ID: 12744751
[TBL] [Abstract][Full Text] [Related]
11. Gene Therapy for beta-thalassemia.
Malik P; Arumugam PI
Hematology Am Soc Hematol Educ Program; 2005; ():45-50. PubMed ID: 16304358
[TBL] [Abstract][Full Text] [Related]
12. Surface engineering of lentiviral vectors for gene transfer into gene therapy target cells.
Lévy C; Verhoeyen E; Cosset FL
Curr Opin Pharmacol; 2015 Oct; 24():79-85. PubMed ID: 26298515
[TBL] [Abstract][Full Text] [Related]
13. Towards more successful gene therapy clinical trials for β-thalassemia.
Drakopoulou E; Papanikolaou E; Georgomanoli M; Anagnou NP
Curr Mol Med; 2013 Sep; 13(8):1314-30. PubMed ID: 23865429
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.
Persons DA
Hematology Am Soc Hematol Educ Program; 2009; ():690-7. PubMed ID: 20008255
[TBL] [Abstract][Full Text] [Related]
15. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
Malik P; Arumugam PI; Yee JK; Puthenveetil G
Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671
[TBL] [Abstract][Full Text] [Related]
16. Improvement of De Novo Cholesterol Biosynthesis Efficiently Promotes the Production of Human Immunodeficiency Virus Type 1-Derived Lentiviral Vectors.
Holic N; Frin S; Seye AK; Galy A; Fenard D
Hum Gene Ther Methods; 2017 Apr; 28(2):67-77. PubMed ID: 28042946
[TBL] [Abstract][Full Text] [Related]
17. CD30 Receptor-Targeted Lentiviral Vectors for Human Induced Pluripotent Stem Cell-Specific Gene Modification.
Friedel T; Jung-Klawitter S; Sebe A; Schenk F; Modlich U; Ivics Z; Schumann GG; Buchholz CJ; Schneider IC
Stem Cells Dev; 2016 May; 25(9):729-39. PubMed ID: 26956718
[TBL] [Abstract][Full Text] [Related]
18. Generation of transgene-free mouse induced pluripotent stem cells using an excisable lentiviral system.
Varga E; Nemes C; Davis RP; Ujhelly O; Klincumhom N; Polgar Z; Muenthaisong S; Pirity MK; Dinnyes A
Exp Cell Res; 2014 Apr; 322(2):335-44. PubMed ID: 24560743
[TBL] [Abstract][Full Text] [Related]
19. Gene Therapy Applications of Non-Human Lentiviral Vectors.
Munis AM
Viruses; 2020 Sep; 12(10):. PubMed ID: 33003635
[TBL] [Abstract][Full Text] [Related]
20. An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells.
Haridhasapavalan KK; Borgohain MP; Dey C; Saha B; Narayan G; Kumar S; Thummer RP
Gene; 2019 Feb; 686():146-159. PubMed ID: 30472380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
